Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
David Malcom Rodman | Chief Medical Officer | 2024-04-12 | 6,349 | $1.08 | $6.86kBuy |
David Malcom Rodman | Chief Medical Officer | 2024-04-11 | 5,017 | $0.54 | $2.71kBuy |
David Malcom Rodman | Chief Medical Officer | 2024-03-12 | 6,348 | $1.08 | $6.86kBuy |
David Malcom Rodman | Chief Medical Officer | 2024-03-11 | 5,017 | $0.54 | $2.71kBuy |
Srinivas Akkaraju | Director | 2024-02-12 | 555,555 | $13.50 | $7.50MBuy |
Ra Capital Management LP | Director | 2024-02-12 | 1,672,508 | $13.50 | $22.58MBuy |
David Malcom Rodman | Chief Medical Officer | 2024-02-12 | 6,349 | $1.08 | $6.86kBuy |
David Malcom Rodman | Chief Medical Officer | 2024-02-12 | 5,017 | $0.54 | $2.71kBuy |
Samsara Biocapital GP LLC | 10% Owner | 2024-02-12 | 555,555 | $13.50 | $7.50MBuy |
David Malcom Rodman | Chief Medical Officer | 2024-01-12 | 6,348 | $1.08 | $6.86kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Catalys Pacific LLC | 18.53% | 9,194,579 | $102.43M | Institution |
Brian Taylor Slingsby | 18.53% | 9,194,579 | $102.43M | Insider |
Samsara Biocapital GP LLC | 10.23% | 5,074,916 | $56.53M | Insider |
Srinivas Akkaraju | 10.23% | 5,074,916 | $56.53M | Insider |
Samsara Biocapital LLC | 9.11% | 4,519,361 | $50.35M | Institution |
Hbm Healthcare Investments Cayman Ltd | 6.48% | 3,218,106 | $35.85M | Insider |
Ra Capital Management LP | 6.40% | 3,178,476 | $35.41M | Insider |
Ra Capital Management LP | 6.40% | 3,178,476 | $35.41M | Institution |
Adams Street Partners LLC | 4.64% | 2,302,329 | $25.65M | Institution |
Braidwell LP | 4.08% | 2,023,900 | $22.55M | Institution |